Menu
Recruiting NCT07665801

Effects of Foot Core Exercises in Patients With Total Hip Arthroplasty

No phase Interventional Total Hip Arthroplasty (THA)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Hip Rehabilitation Exercise Program, Foot-Core Exercise Program.
Who it may be relevant to
Registry conditions: Total Hip Arthroplasty (THA). Basic parameters: 50 years — 80 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Investigation of the Effects of Foot Core Exercises on Lower Extremity Muscle Strength, Functional Parameters, and Morphological and Viscoelastic Properties of Foot and Ankle Periarticular Structures in Patients With Total Hip Arthroplasty

Overview

The goal of this clinical trial is to investigate the effects of foot core exercises on lower extremity muscle strength, viscoelastic properties, functional parameters, foot and ankle posture, balance, and the morphological characteristics of periarticular structures of the foot and ankle in individuals with total hip arthroplasty. The main questions it aims to answer are: * Does foot core exercises affect morphological characteristics of the periarticular structures surrounding the foot and ankle? * Does foot core exercises affect viscoelastic properties of the periarticular structures surrounding the foot and ankle? * Does foot core exercises affect lower extremity muscle strength? * Does foot core exercises affect lower extremity functional parameters and balance in individuals with total hip arthroplasty? The researchers will compare the group performing foot core exercises with the group performing routine hip exercises that do not include foot core exercises. Participitants will: * Participants will receive an exercise log after a specialist physiotherapist demonstrates the exercises in practice at the third postoperative mounth. * Visit the clinic every two months from postoperative mounth 3 to month 7 for routine follow-ups and progression of exercises. * Except for the control sessions held every two mounths, patients will be followed up through weekly phone calls. * Participants will complete an exercise diary indicating that they performed the exercises prescribed for each week, and they will bring their diaries with them to the follow-up sessions.

Interventions

  • Other Hip Rehabilitation Exercise Program
    5 days per week, 40 minutes per session, for 12 weeks.
  • Other Foot-Core Exercise Program
    5 days per week, 40 minutes per session, for 12 weeks

Primary outcome measures

  • Ultrasonographic muscle thickness of foot and ankle periarticular structures [Time frame: From enrollment to the end of treatment at 12 weeks]
  • Ultrasonographic cross-sectional area of foot and ankle periarticular structures [Time frame: From enrollment to the end of treatment at 12 weeks]
  • Tone (frequency) of foot and ankle periarticular structures [Time frame: From enrollment to the end of treatment at 12 weeks]
  • Ultrasonographic tendon morphology of foot and ankle segments [Time frame: From enrollment to the end of treatment at 12 weeks]
  • Stiffness of foot and ankle periarticular structures [Time frame: From enrollment to the end of treatment at 12 weeks]
  • The damping coefficient of foot and ankle periaticular structures [Time frame: From enrollment to the end of treatment at 12 weeks]
  • Relaxation time of foot and ankle periarticular structures [Time frame: From enrollment to the end of treatment at 12 weeks]
  • Creep parameters of foot and ankle periarticular structures [Time frame: From enrollment to the end of treatment at 12 weeks]
Secondary outcome measures (12)
  • Evaluation of lower extremity alignment [Time frame: From enrollment to the end of treatment at 12 weeks]
  • Navicular height during weight-bearing condition [Time frame: From enrollment to the end of treatment at 12 weeks]
  • Assessment of Hip Flexor Muscle Strength [Time frame: From enrollment to the end of treatment at 12 weeks]
  • Assessment of Balance [Time frame: From enrollment to the end of treatment at 12 weeks]
  • Assessment of Hip Functional Status [Time frame: From enrollment to the end of treatment at 12 weeks]
  • Ankle Mobility Measurement [Time frame: From enrollment to the end of treatment at 12 weeks]
  • Assessment of Foot Posture [Time frame: From enrollment to the end of treatment at 12 weeks]
  • Assessment of Kinesiophobia [Time frame: From enrollment to the end of treatment at 12 weeks]
  • Assessment of the Ability to Forget the Artificial Joint [Time frame: From enrollment to the end of treatment at 12 weeks]
  • Assessment of Fear of Falling and Confidence in Avoiding Falls [Time frame: From enrollment to the end of treatment at 12 weeks]
  • Assessment of Quality of Life [Time frame: From enrollment to the end of treatment at 12 weeks]
  • Navicular height during non-weight-bearing condition [Time frame: From enrollment to the end of treatment at 12 weeks]

Eligibility criteria

Inclusion criteria

  • Being between 50 and 80 years old,
  • Having at least 2 months elapsed since total hip arthroplasty surgery,
  • Being willing to participate in the study,
  • Being literate.

Exclusion criteria

  • Having undergone revision total hip arthroplasty surgery,
  • Having a cognitive level below 21 on the MoCA scale, or having any neurological or rheumatological disease,
  • Inability to ambulate,
  • Having any history of lower extremity trauma or other surgical procedures,
  • Having toe-related pathologies that may affect pressure distribution and the course of exercise, such as hallux valgus or Morton's neuroma.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Triple blind
Primary purpose
Treatment

Study locations

Turkey (Türkiye) · 1 center
  • Hacettepe University — Ankara

Identifiers

NCT: NCT07665801 · FTREK26/20

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗